Capturing activity, costs, and outcomes: The challenges to be overcome for successful economic evaluation in palliative care

Progress in Palliative Care

Volumn 21, Issue 4, 2013, Pages 232-235

  Murtagh, Fliss E M ^a   Groeneveld, E Iris ^a   Kaloki, Yvonne E ^a   Calanzani, Natalia ^a   Bausewein, Claudia ^a   Higginson, Irene J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cost effectiveness; Costs; Health economic evaluation; Home care; Palliative care

Indexed keywords

17 METHYLNALTREXONE;

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HOSPITALIZATION COST; PALLIATIVE THERAPY; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 84881651870     PISSN: 09699260     EISSN: 1743291X     Source Type: Journal    
DOI: 10.1179/1743291X12Y.0000000046     Document Type: Article

References (24)

1. Annemans L. Health economics for non-economists: an introduction to the concepts, methods and pitfalls of health economic evaluations. Ghent: Academia Press; 2008.
2. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 2005.
3. Jones J, Wilson A, Parker H, Wynn A, Jagger C, Spiers N, et al. Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial. BMJ 1999;319:1547-50.
4. Pace A, Di Lorenzo C, Capon A, Villani V, Benincasa D, Guariglia L, et al. Quality of care and rehospitalization rate in the last stage of disease in brain tumor patients assisted at home: a cost effectiveness study. J Palliat Med 2012;15(2):225-7.
5. Higginson IJ, McCrone P, Hart SR, Burnman R, Silber E, Edmonds PR. Is short-term palliative care cost-effective in multiple sclerosis? A randomized phase II Trial. J Pain Symptom Manage. 2009;38(6):816-26.
6. Tramarin A, Milocchi F, Tolley K, Vaglia A, Marcolini F, Manfrin V, et al. An economic evaluation of home-care assistance for AIDS patients: a pilot study in a town in northern Italy. AIDS 1991;6(11):1377-83.
7. Iskedjian M, Iyer S, Librach SL, Wang M, Farah B, Berbari J. Methylnaltrexone in the treatment of opioid-induced constipation in cancer patients receiving palliative care: willingnessto-pay and cost-benefit analysis. J Pain Symptom Manage 2011;41(1):104-15.
8. Dumont S, Jacobs P, Turcotte V, Anderson D, Harel F. The trajectory of palliative care costs over the last 5 months of life: a Canadian longitudinal study. Palliat Med 2010;24(6):630-40.
9. Guerriere DN, Zagorski B, Fassbender K, Masucci L, Librach L, Coyte PC. Cost variations in ambulatory and home-based palliative care. Palliat Med 2010;24(5):523-32.
10. Chan ATC, Jacobs P, Yeo W, Lai M, Hazlett CB, Mok TSK, et al. The cost of palliative care for hepatocellular carcinoma in Hong Kong. Pharmacoeconomics 2001;19(9):947-53.
11. Tamir O, Singer Y, Shvartzman P. Taking care of terminally-ill patients at home - the economic perspective revisited. Palliat Med 2007;21:537-41.
12. Hatziandreu E, Archontakis F, Daly A. The potential cost savings of greater use of home- and hospice based end of life care in England. London: National Audit Office; 2008.
13. Bardsley M, Georghiou T, Dixon J. Social care and hospital use at the end of life: The Nuffield Trust. 2010, published online http://www.nuffieldtrust.org.uk/sites/files/nuffield/social_care_and_hospital_use-full_report_081210.pdf.
14. Gomes B, McCrone P, Hall S, Koffman J, Higginson IJ. Variations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study. BMC Cancer 2010;10:400.
15. Bausewein C, Jolley C, Moxham J, Lobo P, Kelly J, Bellas H, et al. Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial. BMC Pulm Med 2012;12(1), published online doi: 10.1186/1471-2466-12-58.
16. Guerriere DN, Coyte PC. The ambulatory and home care record: a methodological framework for economic analyses in end-of-life care. J Aging Res 2011, published online doi: 10.4061/2011/374237.
17. McCorkle R, Benoliel JQ, Donaldson G, Georgiadou F, Moinpour C, Goodell B. A randomized clinical trial of home nursing care of lung cancer patiets. Cancer 1989;64:199-206.
18. Curtis L. Unit Costs of Health and Social Care 2011: Personal Social Services Research Unit (PSSRU). 2011, published online http://www.pssru.ac.uk/pdf/uc/uc2011/uc2011.pdf.
19. Hughes J. Palliative Care and the QALY Problem. Health Care Analysis 2005;13(4):289-301.
20. Round J. Is a QALY still a QALY at the end of life? J Health Econ 2012;31(3):521-7.
21. Normand C. Measuring Outcomes in palliative care: limitations of QALYs and the road to PalYs. J Pain Symptom Manage 2009; 38(1):27-31.
22. McNamee P, Seymour J. Incorporation of process preferences within the QALY framework: a study of alternative methods. Med Decis Making 2008;28(3):443-52.
23. Turner-Stokes L, Sutch S, Dredge R, Eagar K. International casemix and funding models: lessons for rehabilitation. Clin Rehabil 2012;26(3):195-208.
24. Turner-Stokes L, Sutch S, Dredge R. Healthcare tariffs for specialist inpatient neurorehabilitation services: rationale and development of a UK casemix and costing methodology. Clin Rehabil 2012;26(3):264-79.